--- a +++ b/clusters/9knumclustersv2/clust_1016.txt @@ -0,0 +1,123 @@ +Alanine aminotransferase (ALT) =< x ULN +Serum alanine aminotransferase (ALT) < . x ULN +Alanine aminotransferase (ALT) =< . X ULN, within days of registration +Alanine aminotransferase (ALT) =< . x ULN +Alanine aminotransferase (ALT [SGPT]) ?. the ULN; +Alanine aminotransferase (ALT) =< . x ULN +Obtained within days prior to CD: Alanine aminotransferase (ALT) =< x ULN +Alanine aminotransferase (ALT) =< x ULN OR if hepatic involvement by lymphoma: ALT =< x ULN +Alanine aminotransferase (ALT) < x institutional ULN within days of enrollment to trial +Alanine aminotransferase (ALT) =< . X ULN +alanine aminotransferase (ALT) ? . ULN or ? ULN for subjects with known hepatic metastases +Alanine aminotransferase (ALT) =< . x institutional ULN +Within days of the first dose of study drug: Alanine aminotransferase (ALT) =< x ULN +Alanine aminotransferase (ALT) =< . ULN obtained within days prior to initiating study treatment. +Alanine aminotransferase (ALT) level =< . ULN. +Alanine aminotransferase (ALT) < x ULN, unless due to the underlying leukemia approved by the PI +Alanine aminotransferase (ALT) ? x ULN for age, unless elevation is due to leukemic infiltration +Alanine aminotransferase (ALT) ? . x ULN (unless considered due to leukemic organ involvement) +Alanine aminotransferase (ALT) > U/L +Alanine aminotransferase (ALT) =< x ULN. +Alanine aminotransferase (ALT) level =< . x ULN +Alanine aminotransferase (ALT) ? . x ULN +alanine aminotransferase (ALT) <= . x ULN* +Alanine aminotransferase (ALT) =< . x ULN +To be performed within days prior to day of protocol therapy: alanine aminotransferase (ALT) =< . x ULN +Alanine aminotransferase (ALT) =< . x ULN (obtained within three days prior to study treatment) +Alanine aminotransferase (ALT) =< x ULN. +Alanine aminotransferase (ALT) =< . x ULN +Alanine aminotransferase (ALT) =< . x ULN within days of study registration. +Alanine aminotransferase (ALT) (SPGT) is ? X ULN for age +Alanine aminotransferase (ALT) ? . ULN or ? ULN for subjects with known hepatic metastases +Alanine aminotransferase (ALT) =< . x ULN +Alanine aminotransferase (ALT) within . x ULN unless there are liver metastases in which case, ALT within x ULN +Alanine aminotransferase (ALT) =< x ULN. +Alanine aminotransferase (ALT) within . x ULN unless there are liver metastases in which case, ALT within x ULN +ALT (alanine aminotransferase) =< x ULN +Alanine aminotransferase (ALT) =< x ULN +Obtained within days of randomization: Alanine aminotransferase (ALT) =< x ULN +alanine aminotransferase (ALT) ? . ULN* +Alanine aminotransferase (ALT) =< . x ULN prior to biopsy +Alanine aminotransferase (ALT) =< . x ULN +Alanine aminotransferase (ALT) =< . x ULN (obtained within days prior to first study treatment)\r\n* Subjects with documented liver metastases should have ALT =< x ULN +LYMPHODEPLETION: Alanine aminotransferase (ALT) =< . x ULN, obtained within hrs prior to procurement +Within days prior to planned start of treatment: Alanine aminotransferase (ALT) =< x ULN +Alanine aminotransferase (ALT) =< . x ULN for the laboratory +Alanine aminotransferase (ALT) < x ULN +Alanine aminotransferase (ALT) =< . x ULN +Alanine aminotransferase (ALT) =< . x ULN +Alanine aminotransferase (ALT) < . x ULN +Alanine aminotransferase (ALT) =< x ULN for the laboratory +Alanine transaminase (alanine aminotransferase [ALT]) > . x ULN +Alanine aminotransferase (ALT) =< . X ULN +Alanine aminotransferase (ALT) < . x ULN ( x ULN for subjects on chronic anticonvulsive therapies known to increase transaminases). +Alanine aminotransferase (ALT) =< x ULN for the laboratory, except in the presence of known hepatic metastasis, wherein the ALT may be =< x ULN +Within months of registration: Alanine aminotransferase (ALT) =< . x ULN +Within days prior to study entry: Alanine aminotransferase (ALT) =< x ULN +Alanine aminotransferase (ALT) =< . x ULN for the laboratory +Alanine aminotransferase (ALT) =< . x ULN +AT THE TIME OF INFUSION: Alanine aminotransferase (ALT) ? x normal +Alanine aminotransferase (ALT) =< . x ULN +Within weeks of enrollment: Alanine aminotransferase (ALT) =< x normal range +Alanine aminotransferase (ALT) =< IU/L +Alanine aminotransferase (ALT) =< x ULN unless considered due to leukemic involvement +Alanine aminotransferase (ALT) =< x ULN +Alanine aminotransferase (ALT) > x ULN +Alanine aminotransferase (ALT) ? units per Liter (U/L). For the purpose of this study, the ULN for ALT is U/L +Alanine aminotransferase (ALT) > . X ULN or cirrhosis +Alanine aminotransferase (ALT) within the reference range during screening evaluation +Alanine aminotransferase (ALT) > x ULN +To be performed within days prior to day of protocol therapy: alanine aminotransferase (ALT) =< x ULN\r\n* If hepatic involvement by lymphoma: ALT =< x ULN +Within days prior to day of protocol therapy unless otherwise stated: Alanine aminotransferase (ALT) =< x ULN +Alanine aminotransferase (alanine transaminase [ALT]) =< . x ULN, obtained =< days prior to registration +Alanine aminotransferase (ALT) =< . x ULN for the laboratory +Alanine aminotransferase (ALT) =< x ULN +Alanine aminotransferase (ALT) < . X ULN; patients with Gilbert's disease are exempt from this criteria +Alanine aminotransferase (ALT) =< . x ULN +Alanine aminotransferase (ALT) =< x ULN for the laboratory +Alanine aminotransferase (ALT) =< . x ULN without, and =< x ULN with hepatic metastasis +Alanine aminotransferase (ALT) ? x ULN +Alanine aminotransferase (ALT) =< x ULN within days prior to study registration +Alanine aminotransferase (ALT) =< . x ULN without, and =< x ULN with hepatic metastasis +Alanine aminotransferase (ALT) =< . x ULN +Alanine aminotransferase (ALT) =< . x ULN +Alanine aminotransferase less than or equal to x ULN +Alanine aminotransferase (ALT) =< x ULN +Alanine aminotransferase (ALT) =< . x ULN +Within h of initiating study treatment: Alanine aminotransferase (ALT) =< . x ULN OR < x ULN for liver mets +Alanine aminotransferase (ALT) =< . X ULN +Alanine aminotransferase (ALT) > . x ULN +and alanine aminotransferase (ALT) ? . ULN or ? ULN for subjects with known hepatic metastases +alanine aminotransferase (ALT) less than or equal to . ULN* +Alanine aminotransferase (ALT) ? . x ULN unless there is hepatic involvement, then x ULN +Alanine aminotransferase (ALT) ? institutional ULN +Within days prior to initiation of protocol treatment: Alanine aminotransferase (ALT) =< . x ULN +Alanine aminotransferase (ALT) =< x ULN +Alanine aminotransferase (ALT) =< . x ULN +Alanine aminotransferase (ALT) =< . x ULN +Alanine aminotransferase (ALT) < x ULN age +Alanine aminotransferase (ALT) =< . x ULN +Alanine aminotransferase (ALT) =< . x ULN +Alanine aminotransferase (ALT) ? . ULN or ? ULN for subjects with known hepatic metastases +Alanine aminotransferase > IU/L +Alanine aminotransferase (ALT) ? ULN +Alanine aminotransferase (ALT) < x ULN +Alanine aminotransferase (ALT) =< . x ULN (=< . x ULN if considered due to leukemic involvement) +Alanine aminotransferase (ALT) < IU/ml +Alanine aminotransferase (ALT) =< . x ULN +Alanine aminotransferase (ALT) =< . X ULN +Alanine aminotransferase (ALT) =< . x the ULN (in the absence of hepatic involvement of tumor) +Alanine aminotransferase (ALT) ?xULN +Alanine aminotransferase (ALT) =< x ULN for age, unless the elevation is disease-related +Alanine aminotransferase (ALT) =< x ULN +Alanine aminotransferase (ALT) =< . x ULN +Alanine aminotransferase (ALT) > x ULN for the laboratory +Serum alanine aminotransferase ? (ALT) . x ULN +Alanine aminotransferase (ALT) =< . x ULN +Obtained within days prior to registration: Alanine aminotransferase (ALT) =< . x ULN (subjects with documented liver metastases should have ALT =< x ULN) +Alanine aminotransferase (ALT) < ULN unless hepatic metastases are present, then < ULN +Alanine aminotransferase (ALT) =< . X ULN +Alanine aminotransferase (ALT) =< . x ULN (=< . x in case of liver mets), within weeks prior to study start +Alanine aminotransferase (ALT) =< . x ULN +Alanine aminotransferase (ALT) =< . x ULN +Alanine aminotransferase =< IU/dL